THERAPEUTIC IMPLICATIONS OF BIOAVAILABILITY

被引:8
作者
AZARNOFF, DL
HUFFMAN, DH
机构
[1] UNIV KANSAS,MED CTR,DEPT MED,KANSAS CITY,KS 66103
[2] UNIV KANSAS,MED CTR,DEPT PHARMACOL,KANSAS CITY,KS 66103
[3] VET ADM HOSP,KANSAS CITY,MO 64128
关键词
D O I
10.1146/annurev.pa.16.040176.000413
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:53 / 66
页数:14
相关论文
共 128 条
[1]   POTASSIUM-INDUCED LESIONS OF SMALL BOWEL .2. PATHOLOGY AND PATHOGENESIS [J].
ALLEN, AC ;
BOLEY, SJ ;
SCHULTZ, L ;
SCHWARTZ, S .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1965, 193 (12) :1001-&
[2]  
Balla J, 1968, Med J Aust, V2, P480
[3]  
BARR W H, 1969, Drug Information Bulletin, V3, P27
[4]  
BARR WH, 1972, CLIN PHARMACOL THER, V13, P97
[5]  
BARRY AL, 1968, ANTIMICROBIAL AGENTS, P415
[6]   ABSORPTION AND EXCRETION OF 2 CHLORAMPHENICOL PRODUCTS IN HUMANS AFTER ORAL ADMINISTRATION [J].
BARTELLONI, PJ ;
CALIA, FM ;
MINCHEW, BH ;
BEISEL, WR ;
LEY, HL .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1969, 258 (03) :203-+
[7]   COMPARISON OF BUFFERED AND UNBUFFERED ACETYLSALICYLIC ACID [J].
BATTERMAN, RC .
NEW ENGLAND JOURNAL OF MEDICINE, 1958, 258 (05) :213-219
[9]  
BELLER GA, 1971, NEW ENGLAND J MED, V284, P979
[10]  
BENISHAY D, 1973, CLIN PHARMACOL THER, V14, P250